FDA Inspection
Robert Litman, M.D.Robert Litman, M.D. – FDA Inspection, Feb 20, 2020
Record Details
This FDA Inspection record concerns Robert Litman, M.D., with an inspection on February 20, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Robert Litman, M.D.
- Inspection Date
- February 20, 2020
- Product Type
- Drugs
View Company Profile
ID · 1e74bc9b-1ed3-4969-9cfd-35fc95e70562
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1118290
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Robert Litman, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 4, 2025 | Not classified | Baltimore District Office | |
| January 29, 2013 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Robert Litman, M.D.
- FDA Inspection 1264213 - 2025-03-04
- FDA Inspection 819517 - 2013-01-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.